Clinical Trial Update: A Study of CS060380 Tablets in Patients With MASH and Obesity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicating that CS060380 tablets for metabolic dysfunction-associated steatohepatitis and obesity are currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis
• Obesity

Drugs mentioned

• CS060380 Tablets (CS060380)

Snippet

Sponsor: Cascade Pharmaceuticals, Inc | Conditions: Metabolic Dysfunction-associated Steatohepatitis (MASH), Obesity | Phase 2 | Status: RECRUITING